Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.
Banerji
A
A
Communicable Diseases Control, Toronto Public Health.
Tyler
I
I
Finkelstein
M S
MS
Gournis
E
E
Pritchard
M F
MF
Kolbe
F
F
Shahin
R
R
D002170:Canada; D003362:Cost-Benefit Analysis; D006302:Health Services Research; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D007326:Institutionalization; D008134:Long-Term Care; D009735:Nursing Homes; D016896:Treatment Outcome; D015164:Vaccines, Inactivated / Q000276:immunology / Q000627:therapeutic use*
D007252:Influenza Vaccines; D015164:Vaccines, Inactivated